| |
 |
|
Meessen JMTA, Bär C, di Dona FM, Staszewsky LI, Di Giulio P, Di Tano G, Costa A, Leonardy J, Novelli D, Nicolis EB, Masson S, Pinet F, Thum T, Latini R | LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial
Clin Chem 2021. 67 (12) : 1721 - 1731 |
Targher G, Lunardi G, Mantovani A, Meessen J, Bonapace S,Temporelli PL, Nicolis E, Novelli D, Conti A, Tavazzi L, Maggioni AP, Latini R | Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial
ESC Heart Failure 2020. DOI: 10.1002/ehf2.12885 |
Ameri P, Canepa M, Nicolosi GL, Marchioli R, Latini R, Tavazzi L, Maggioni AP; GISSI-HF Investigators. | Cancer in chronic heart failure patients in the GISSI-HF trial.
Eur J Clin Invest 2020. 50(9) : e13273 |
Canepa M, Siri G, Puntoni M, Latini R, Tavazzi L, Maggioni AP | Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database
Int J Cardiol 2020. 313 : 89 - 96 |
Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators. | Modes of death and prognostic outliers in chronic heart failure.
Am Heart J 2019. 208 : 100 - 109 |
Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, Køber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. | Declining Risk of Sudden Death in Heart Failure.
N Engl J Med 2017. 377(1) : 41 - 51 |
Damman K, Masson S, Lucci D, Gorini M, Urso R, Maggioni AP, Tavazzi L, Tarantini L, Tognoni G, Voors A, Latini R | Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF
J Cardiac Failure 2017. 23 (1) : 2 - 9 |
Sanders-van Wijk S, Masson S, Milani V, Rickenbacher P, Gorini M, Tavazzi LT, Tobler D, Rickli H, Latini R, Brunner-La Roccaenen HP; TIME-CHF Investigators and the GISSI-HF Investigators. | Interaction of Galectin-3 Concentrations with the Treatment Effects of Beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF.
Clin Chem 2016. 62 (4) : 605 - 616 |
Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M, Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators. | Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers.
Circ Heart Fail 2015. 8 (3) : 428 - 437 |
Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA); GISSI-Heart Failure (GISSI-HF) Committees and Investigators. | Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Circulation 2015. 131 (17) : 1486 - 1494 |
Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, Clemenza F, Tognoni G, Anand IS, Cohn JN, Anker SD, Tavazzi L, Latini R; GISSI-HF and Val-HeFT Investigators. | Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
Eur J Heart Fail 2015. 17 (4) : 424 - 433 |
Feinstein MJ, Jhund P, Kang J, Ning H, Maggioni A, Wikstrand J, Kjekshus J, Tavazzi L, McMurray J, Lloyd-Jones DM. | Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
Eur J Heart Fail 2015. 17 (4) : 434 - 441 |
Perrone-Filardi P, Savarese G, Scarano M, Cavazzina R, Trimarco B, Minneci S, Maggioni AP, Tavazzi L, Tognoni G, Marchioli R. | Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from GISSI-HF trial.
Int J Cardiol 2015. 178 : 85 - 90 |
Cannone V, Barlera S, Pileggi S, Masson S, Franzosi MG, Latini R, Scardulla C, Clemenza F, Maggioni AP, Nicolosi GL, Tavazzi L, Burnett JC Jr; GISSI-HF Investigators. | The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure.
Int J Cardiol 2014. 176 (3) : 1249 - 1251 |
Pileggi S, Barlera S, Nicolis EB, Crociati L, Pietri S, Specchia C, Franzosi MG. | Association of ADIPOQ variants and heart failure in an Italian population.
Ther Adv Cardiovasc Dis 2014. 8 (3) : 89 - 96 |
Askevold ET, Aukrust P, Nymo SH, Lunde IG, Kaasbøll OJ, Aakhus S, Florholmen G, Ohm IK, Strand ME, Attramadal H, Fiane A, Dahl CP, Finsen AV, Vinge LE, Christensen G, Yndestad A, Gullestad L, Latini R, Masson S, Tavazzi L; GISSI-HF Investigators, Ueland T. | The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure.
J Intern Med 2014. 275 (6) : 621 - 630 |
Network of Nurses of GISSI-HF, Di Giulio P. | Should patients perception of health status be integrated in the prognostic assessment of heart failure patients? A prospective study.
Qual Life Res 2014. 23 (1) : 49 - 56 |
Barlera S, Tavazzi L, Franzosi MG, Marchioli R, Raimondi E, Masson S, Urso R, Lucci D, Nicolosi GL, Maggioni AP, Tognoni G, GISSI-HF Investigators | Predictors of Mortality in 6975 Patients with Chronic Heart Failure in the GISSI-HF Trial: Proposal for a Nomogram
Circ Heart Fail 2013. 6 : 31 - 39 |
La Rovere MT, Staszewsky L, Barlera S, Maestri R, Mezzani A, Midi P, Marchioli R, Maggioni AP, Tognoni G, Tavazzi L, Latini R, GISSI-HF Investigators | n-3PUFA and holter derived autonomic variables in heart failure patients: Data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter Substudy
Heart Rhythm 2013. 10 : 226 - 232 |
Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R, on behalf of the GISSI-HF Investigators | Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure trial: Relation with fish intake, circulating biomarkers and mortality
Am Heart J 2013. 165 : 208 - 215.e4 |
Ueland T, Nymo S H , Latini R, McMurray J J V, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni A P, Gullestad L, Aukrust P, on behalf of the Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) , GISSI-Heart Failure (GISSI-HF) trials | CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials
Eur Heart J Fail 2013. 15 : 747 - 755 |
Aleksova A, Masson S, Maggioni AP, Lucci D, Fabbri G, Beretta L, Mos L, Paino AM, Nicolosi GL, Marchioli R, Tognoni G, Tavazzi L, Sinagra G, Latini R, on behalf of the GISSI-Heart Failure (GISSI-HF) Investigators | n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial
Eur Heart J Fail 2013. E-pub |
Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, Proietti G, Barbuzzi S, Nicolosi GL, Tavazzi L, Maggioni AP, Latini R | Tubular damage and worsening renal function in chronic heart failure
J Am Coll Cardiol HF 2013. 1 : 417 - 424 |
La Rovere MT, Pinna GD, Maestri R, Barlera S, Bernardinangeli M, Veniani M, Nicolosi GL, Marchioli R, Tavazzi L, for the GISSI-HF Investigators | Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial
Eur Heart J Fail 2012. 14 : 1410 - 1419 |
Latini R, Gullestad L, Masson S, Nymo SH , Ueland T, Cuccovillo I, Vårdal M , Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L, Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trial | Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
Eur J Heart Fail 2012. 14 : 992 - 999 |
Finzi AA, Latini R, Barlera S, Rossi MG, Ruggeri A, Mezzani A, Favero C, Franzosi MG, Serra D, Lucci D, Bianchini F, Bernasconi R, Maggioni AP, Nicolosi G,Porcu M,Tognoni G, Tavazzi L, Marchioli R | Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial
Am Heart J 2011. 161 (2) : 338 - 343 |
Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M, Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L, Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators. | Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial
Expert Rev Cardiovasc Ther 2009. 7(7) : 735 - 748 |
Tavazzi L, Nodari S | Lo studio GISSI-HF.
G Ital Cardiol 2009. 10 : 129 - 134 |
Maggioni AP, Fabbri G, Lucci D, Marchioli R, Franzosi MG, Latini R, Nicolosi GL, Porcu M, Cosmi F, Stefanelli S, Tognoni G, Tavazzi L; GISSI-HF Investigators. | Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Eur Heart J 2009. 30(19) : 2327 - 2336 |
GISSI-HF Investigators | Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008. 372 : 1223 - 1230 |
GISSI-HF Investigators | Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Lancet 2008. 372 : 1231 - 1239 |
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL and Porcu M, on behalf of GISSI-HF Investigators | Rationale and Design of the GISSI Heart Failure Trial: a Large Trial to Assess the Effects of n-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure
Eur J Heart Fail 2004. 6 : 635 - 641 | |
|
